Postpartum pElvic Assisted Recovery With Leva (PEARL)

July 24, 2025 updated by: University of South Florida

Feasibility of Pelvic Floor Muscle Training With a Digital Therapeutic Motion-based Device (Leva Device) in a Postpartum Population

The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.

In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.

Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Florida
      • Tampa, Florida, United States, 33606
        • Recruiting
        • University of South Florida
        • Contact:
        • Principal Investigator:
          • Katie Propst, MD
    • Ohio
      • Columbus, Ohio, United States, 43210
        • Recruiting
        • Ohio State University Wexner Medical Center
        • Contact:
        • Principal Investigator:
          • Lisa Hickman, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Spontaneous vaginal delivery within the last 4-8 weeks
  • Age ≥ 18 years
  • Ambulatory
  • Willing and able to consent to participate.
  • English speaking
  • Owns a smartphone

Exclusion Criteria:

  • Operative or cesarean delivery
  • Obstetric delivery at less than 20 weeks gestation
  • Third- or fourth-degree perineal laceration
  • Episiotomy
  • Multiples

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Device Arm
Participants in this arm will use a digital therapeutic motion-based device for postpartum pelvic floor muscle training
This intervention includes use of a digital therapeutic motion-based device for pelvic floor muscle training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility
Time Frame: From enrollment to 6 months postpartum
Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.
From enrollment to 6 months postpartum
Perineal Pain
Time Frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.
From enrollment to 6 months postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bladder function
Time Frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing bladder function at baseline, 3 months postpartum, and 6 months postpartum.
From enrollment to 6 months postpartum
Bowel Function
Time Frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing bowel function at baseline, 3 months postpartum, and 6 months postpartum.
From enrollment to 6 months postpartum
Pelvic Organ Prolapse
Time Frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing pelvic organ prolapse symptoms at baseline, 3 months postpartum, and 6 months postpartum.
From enrollment to 6 months postpartum
Vaginal pain
Time Frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing vaginal pain at baseline, 3 months postpartum, and 6 months postpartum.
From enrollment to 6 months postpartum
Sexual function
Time Frame: From enrollment to 6 months postpartum
Participants will complete validated surveys assessing sexual function at 3 months postpartum and 6 months postpartum.
From enrollment to 6 months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 4, 2025

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

September 20, 2024

First Submitted That Met QC Criteria

September 20, 2024

First Posted (Actual)

September 24, 2024

Study Record Updates

Last Update Posted (Actual)

July 29, 2025

Last Update Submitted That Met QC Criteria

July 24, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Pelvic Floor Function and Symptoms

Clinical Trials on Digital therapeutic motion-based device

Subscribe